Ady Castro-Acosta

Ady Castro-Acosta

Auto-generated profile, based on publicly available information

Ady Castro-Acosta

Servicio de Neumología, Hospital 12 de Octubre, 28041 Madrid, Spain

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2015 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
SHSylvia Hartl
Sylvia Hartl
Jose Luis Lopez-CamposJose Luis Lopez-Campos
Jose Luis Lopez-Campos
FPFrancisco Pozo-Rodriguez
Francisco Pozo-Rodriguez
ACAdy Castro-Acosta
Ady Castro-Acosta
MSMichael Studnicka
Michael Studnicka
CRC. Michael Roberts
C. Michael Roberts
Studies report high in-hospital and post-discharge mortality of chronic obstructive pulmonary disease (COPD) exacerbations varying depending upon patient characteristics, hospital resources and treatment standards. This study aimed to investigate the patient, resource and organisational factors associated with in-hospital and 90-day post-discharge mortality and readmission of COPD exacerbations within the European COPD Audit. The audit collected data of COPD exacerbation admissions from 13 European countries.On admission, only 49.7% of COPD patients had spirometry results available and only 81.6% had blood gases taken. Using logistic regression analysis, the risk associated with in-hospital and post-discharge mortality was higher age, presence of acidotic respiratory failure, subsequent need for ventilatory support and presence of comorbidity. In addition, the 90-day risk of COPD readmission was associated with previous admissions. Only the number of respiratory specialists per 1000 beds, a variable related to hospital resources, decreased the risk of post-discharge mortality.The European COPD Audit identifies risk factors associated with in-hospital and post-discharge mortality and COPD readmission. Addressing the deficiencies in acute COPD care such as making spirometry available and measuring blood gases and providing noninvasive ventilation more regularly would provide opportunities to improve COPD outcomes.

26 March 2013 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
JCJesús Castilla
Jesús Castilla
PGPere Godoy
Pere Godoy
ÁDÁngela Domínguez
Ángela Domínguez
IMIván Martínez-Baz
Iván Martínez-Baz
JAJenaro Astray
Jenaro Astray
MMM. Morales
M. Morales
Background. In most seasons, the influenza vaccine is effective in preventing influenza, but it is not clear whether it is equally effective in preventing mild and severe cases. We designed a case-control study to compare the effectiveness of the influenza vaccine in preventing outpatient, inpatient, and severe or fatal cases of laboratory-confirmed influenza. Methods. Hospitalized patients (n = 691) with laboratory-confirmed influenza in the 2010–2011 season recruited in 29 Spanish hospitals were individually matched by age, admission/visit date, and province with an outpatient with laboratory-confirmed influenza and an outpatient control. Severe cases were considered those patients admitted to intensive care units or who died in the hospital (n = 177). We compared the influenza vaccine status of controls and outpatient cases, inpatient cases, and severe cases using conditional logistic regression adjusted for potential confounding factors. Severe and nonsevere inpatient influenza cases were compared using unconditional logistic regression. Vaccine effectiveness was (1 – odds ratio) × 100. Results. Vaccine effectiveness was 75% (adjusted odds ratio [AOR], 0.25; 95% confidence interval [CI], .16–.39) in preventing influenza outpatient cases, 60% (AOR, 0.40; 95% CI, .25–.63) in preventing influenza-associated hospitalizations, and 89% (AOR, 0.11; 95% CI, .04–.37) in preventing severe cases. In inpatients, influenza vaccination was associated with a lower risk of severe influenza (AOR, 0.42; 95% CI, .22–.80). Conclusions. Influenza vaccination prevented influenza cases and hospitalizations and was associated with a better prognosis in inpatients with influenza. The combined effect of these 2 mechanisms would explain the high effectiveness of the vaccine in preventing severe cases due to influenza.

1 January 2016 in ERJ Open Research
Verified
Journal Article
Open access
PDF file
MRMamta Ruparel
Mamta Ruparel
Jose Luis Lopez-CamposJose Luis Lopez-Campos
Jose Luis Lopez-Campos
ACAdy Castro-Acosta
Ady Castro-Acosta
SHSylvia Hartl
Sylvia Hartl
FPFrancisco Pozo-Rodriguez
Francisco Pozo-Rodriguez
CRC. Michael Roberts
C. Michael Roberts
Chronic obstructive pulmonary disease (COPD) care across Europe has high heterogeneity with respect to cost and the services available. Variations in length of stay (LOS) may be attributed to patient characteristics, resource and organisational characteristics, and/or the so-called hospital cluster effect.The European COPD Audit in 13 countries included data from 16 018 hospitalised patients. The recorded variables included information on patient and disease characteristics, and resources available. Variables associated with LOS were evaluated by a multivariate, multilevel analysis.Mean±sdLOS was 8.7±8.3 days (median 7 days, interquartile range 4–11 days). Crude variability between countries was reduced after accounting for clinical factors and the clustering effect. The main factors associated with LOS being longer than the median were related to disease or exacerbation severity, including GOLD class IV (OR 1.77) and use of mechanical ventilation (OR 2.15). Few individual resource variables were associated with LOS after accounting for the hospital cluster effect.This study emphasises the importance of the patients' clinical severity at presentation in predicting LOS. Identifying patients at risk of a long hospital stay at admission and providing targeted interventions offers the potential to reduce LOS for these individuals. The complex interactions between factors and systems were more important that any single resource or organisational factor in determining differences in LOS between hospitals or countries.

24 June 2019 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
LMLaura Millares
Laura Millares
SPSergi Pascual
Sergi Pascual
CMConcepción Montón
Concepción Montón
MGMarian Garcia-Nuñez
Marian Garcia-Nuñez
CLCristina Lalmolda
Cristina Lalmolda
EMEduard Monsó
Eduard Monsó
The respiratory microbiome is altered in COPD patients but its relationship with core components of the disease, such as the severity of airflow limitation, the frequency of exacerbations or the circulating levels of eosinophils, is unclear. Cross-sectional study comprising 72 clinically stable COPD patients (mean age 68 [SD 7.9] years; FEV1 48.7 [SD 20.1]% of reference) who provided spontaneous sputum samples for 16S rRNA gene amplification and sequencing. The microbiome composition was analysed with QIIME. We observed that: (1) more severe airflow limitation was associated with reduced relative abundance (RA) of Treponema and an increase in Pseudomonas; (2) patients with ≥2 exacerbations the previous year showed a significantly different bacterial community with respect to non-exacerbators (p = 0.014), with changes in 13 genera, including an increase of Pseudomonas, and finally, (3) peripheral eosinophils levels ≥2% were associated with more diverse microbiome [Chao1 224.51 (74.88) vs 277.39 (78.92) p = 0.006; Shannon 3.94 (1.05) vs 4.54 (1.06) p = 0.020], and a significant increase in the RAs of 20 genera. The respiratory microbiome in clinically stable COPD patients varies significantly according to the severity of airflow limitation, previous history of exacerbations and circulating eosinophils levels.

1 December 2015 in BMC Public Health
Verified
Journal Article
Open access
PDF file
Vicente MartínVicente Martín
Vicente Martín
VDVeronica Davila-Batista
Veronica Davila-Batista
JCJesús Castilla
Jesús Castilla
PGPere Godoy
Pere Godoy
Miguel Delgado-RodríguezMiguel Delgado-Rodríguez
Miguel Delgado-Rodríguez
Ángela DomínguezÁngela Domínguez
Ángela Domínguez
Obesity is a world-wide epidemic whose prevalence is underestimated by BMI measurements, but CUN-BAE (Clínica Universidad de Navarra - Body Adiposity Estimator) estimates the percentage of body fat (BF) while incorporating information on sex and age, thus giving a better match. Our aim is to compare the BMI and CUN-BAE in determining the population attributable fraction (AFp) for obesity as a cause of chronic diseases. We calculated the Pearson correlation coefficient between BMI and CUN-BAE, the Kappa index and the internal validity of the BMI. The risks of arterial hypertension (AHT) and diabetes mellitus (DM) and the AFp for obesity were assessed using both the BMI and CUN-BAE. 3888 white subjects were investigated. The overall correlation between BMI and CUN-BAE was R2 = 0.48, which improved when sex and age were taken into account (R2 > 0.90). The Kappa coefficient for diagnosis of obesity was low (28.7 %). The AFp was 50 % higher for DM and double for AHT when CUN-BAE was used. The overall correlation between BMI and CUN-BAE was not good. The AFp of obesity for AHT and DM may be underestimated if assessed using the BMI, as may the prevalence of obesity when estimated from the percentage of BF.

6 August 2015 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
RFRosa Faner
Rosa Faner
AGAlba Gutiérrez-Sacristán
Alba Gutiérrez-Sacristán
ACAdy Castro-Acosta
Ady Castro-Acosta
SGSolène Grosdidier
Solène Grosdidier
WGWenqi Gan
Wenqi Gan
AAAlvar Agustí
Alvar Agustí
The frequent occurrence of comorbidities in patients with chronic obstructive pulmonary disease (COPD) suggests that they may share pathobiological processes and/or risk factors.To explore these possibilities we compared the clinical diseasome and the molecular diseasome of 5447 COPD patients hospitalised because of an exacerbation of the disease.The clinical diseasome is a network representation of the relationships between diseases, in which diseases are connected if they co-occur more than expected at random; in the molecular diseasome, diseases are linked if they share associated genes or interaction between proteins.The results showed that about half of the disease pairs identified in the clinical diseasome had a biological counterpart in the molecular diseasome, particularly those related to inflammation and vascular tone regulation. Interestingly, the clinical diseasome of these patients appears independent of age, cumulative smoking exposure or severity of airflow limitation.These results support the existence of shared molecular mechanisms among comorbidities in COPD.